On June 16, Reuters was 17 seconds ahead when Curevac said its COVID vaccine was only 47% effective. When subsequent trial data released on June 30 confirmed this low efficacy, Reuters was minutes ahead of the competition with the news.
Health
Curevac’s COVID vaccine
16 June 2021, 2:10 pm 1 minute
Market Impact
The news of the vaccine effectiveness on June 16 more than halved the value of Curevac shares. After the trial data release a few weeks later, the company’s shares sunk by another 10%.
Article Tags
Topics of Interest: Health
Type: Reuters News First
Sectors: Pharmaceuticals & Healthcare
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Major Global Story
